2024 brought pivotal advances in neurodegenerative biomarkers for early Alzheimer’s detection, insights into amyloid-targeted therapies and patient selection, and new strategies for ARIA risk assessment and management.
REVISIT 2024 Conference Highlights for Alzheimer’s Disease
We have all of our Experts in conversation videos in one place for you to dive into and enjoy before the conference season starts in 2025.
Pick the ones you want to watch and listen to our experts discuss what this new era of disease-modifying therapy will bring to people affected by Alzheimer’s disease.
You can earn a total of 1.5 credits for all four videos (ADPD/CONy: 0.5, AAIC: 0.5, and CTAD Part 1 & 2 together: 0.5). If you are claiming credits for CTAD videos, you can only claim 0.5 credits in total. You are only able to earn one certificate for both activities.
